Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Alnylam Announces Appointment of Peter Kellogg to Board of Directors
Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to […]
Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman
Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with […]
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Capsida Biotherapeutics today announced the appointment of Susan Catalano as the company’s Chief Scientific Officer (CSO). Dr. […]
Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company's Board of Directors
Artax Biopharma, a clinical-stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today […]
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
Corbus Pharmaceuticals, a precision oncology company, today announced the appointment of Yong Ben, M.D., MBA, […]
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and […]
Aadi Bioscience Announces Leadership Transition
Aadi Bioscience, a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations […]
Sitero Appoints Jeff Huntsman as Chief Commercial Officer
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team […]
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced today that Matthew […]
Aptar Appoints Julie Xing to its Board of Directors
Aptar Group, a global leader in drug delivery, consumer product dispensing and active material science […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more